Pdp (66267 325 30 J32)
Terazosin
Product Images NDC 66267-325
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 66267-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)
Figure 1 (Terazosin Hydrochloride Capsules 2)
Figure 2 (Terazosin Hydrochloride Capsules 3)
This text provides a table of mean change from baseline values at different time points. It is not possible to infer further meaning from this incomplete text.*
Figure 3 (Terazosin Hydrochloride Capsules 4)
This appears to be a chart or graph showing measurements in milliliters per second (mL/sec) over time (in months). The values are given at the timepoints 0, 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30 months. However, there is no clear indication of what is being measured or what the context of the data is.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
